Latest Articles about CELG

Market Close Report: NASDAQ Composite index closes at 3,465.24 down -6.38 points

NASDAQ.com News — Fri, 17 May 2013 00:45:13 Z

Thursday's session closes with the NASDAQ Composite Index at 3,465.24. The total shares traded for the NASDAQ was over 1.91 billion. Declining stocks led advancers by 1.33 to 1 ratio. There were

Myriad Soars Higher on Celeb Clout - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 22:27:06 Z

Shares of Myriad Genetics Inc. ( MYGN ) touched a new 52-week high of $34.70 on Tuesday, May 14, 2013 following news out of Hollywood. Academy Award winning Hollywood star Angelina Jolie

Wider-Than-Expected Loss at Athersys - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 18:29:34 Z

Athersys, Inc. 's ( ATHX ) first quarter 2013 adjusted net loss of 13 cents per share was wider than the Zacks Consensus Estimate of a loss of 10 cents. Lower-than-expected revenues were

Celgene Attains 52-Week High - Analyst Blog

Zacks Equity Research — Tue, 14 May 2013 21:07:16 Z

Shares of Celgene Corporation ( CELG ) hit a 52-week high of $131.13 in the first half of the trading session on May 13. This biopharmaceutical stock gained significant momentum following

NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog

Zacks Equity Research — Tue, 14 May 2013 18:23:01 Z

NPS Pharmaceuticals, Inc. ( NPSP ) reported first quarter 2013 net loss per share of 9 cents per share, narrower than the Zacks Consensus Estimate of a loss of 13 cents and the year-ago

Setback for Endo Health on Opana ER - Analyst Blog

Zacks Equity Research — Tue, 14 May 2013 02:05:22 Z

Endo Health Solutions Inc. ( ENDP ) recently suffered a setback with the US Food and Drug Administration (FDA) turning down its request to prevent the entry of generic versions of the

Genomic Gains Coverage for DCIS - Analyst Blog

Zacks Equity Research — Mon, 13 May 2013 23:17:06 Z

Genomic Health Inc. ( GHDX ) continues to make strides towards establishing coverage for its Oncotype DX breast cancer test. The company disclosed that the assigned contractor for its

Earnings Beat at Warner Chilcott - Analyst Blog

Zacks Equity Research — Mon, 13 May 2013 18:48:01 Z

Warner Chilcott' s ( WCRX ) first quarter 2013 earnings (excluding special items) of 92 cents per share handsomely beat the Zacks Consensus Estimate of 85 cents. Lower selling, general

After Hours Most Active for May 10, 2013 : HAL, BAC, GM, SINA, QQQ, LYB, PCG, SYMC, DDD, CELG, INTC, ICON

NASDAQ.com News — Sat, 11 May 2013 00:44:02 Z

The NASDAQ 100 After Hours Indicator is up .06 to 2,981.08. The total After hours volume is currently 13,758,617 shares traded. The following are the most active stocks for the after hours

Positive Data on Celgene's Apremilast - Analyst Blog

Zacks Equity Research — Fri, 10 May 2013 00:23:59 Z

Celgene Corporation ( CELG ) recently announced positive results from the PALACE 4 study on apremilast. The study is evaluating apremilast (20 mg and 30 mg), a novel, oral small-molecule

Narrower Loss from Onyx, Guidance Maintained - Analyst Blog

Zacks Equity Research — Thu, 09 May 2013 02:25:08 Z

Narrower Loss from Onyx, Guidance Maintained Onyx Pharmaceuticals Inc. ( ONXX ) reported a loss of 32 cents per share in the first quarter of 2013, well below the Zacks Consensus

Good News for Bristol-Myers - Analyst Blog

Zacks Equity Research — Tue, 07 May 2013 00:23:33 Z

Bristol-Myers Squibb Company ( BMY ) recently received positive news from the US Food and Drug Administration (FDA) when the US regulatory authority approved the pharma major's HIV drug

Eylea Drives Earnings at Regeneron - Analyst Blog

Zacks Equity Research — Fri, 03 May 2013 22:35:14 Z

Regeneron Pharmaceuticals Inc .'s ( REGN ) first quarter 2013 earnings (excluding special items but including stock-based compensation) of $1.30 per share breezed past the Zacks Consensus

Mylan Reports in line Earnings - Analyst Blog

Zacks Equity Research — Fri, 03 May 2013 16:31:34 Z

Mylan, Inc. 's ( MYL ) first quarter 2013 earnings (excluding special items) of 62 cents per share were in line with the Zacks Consensus Estimate. Earnings increased 19% from the year-ago

Top Fund Buys Focus On Defensive Stocks, Housing

Investor's Business Daily — Fri, 03 May 2013 01:45:00 Z

April notched another month of gains for the stock market. That's four straight months so far this year. But this market rally is getting long in the tooth and top fund managers have been